Salwa Almefareh: Bringing Life-Changing Haemophilia Care to Patients Worldwide
Salwa Almefareh, Regulatory Affairs Specialist at Roche Middle East, Mohamed Naser Al-Hajery and Sons Ltd., shared a post on LinkedIn:
“True innovation in haemophilia A extends beyond scientific discovery, it is realized when innovation reaches the patients who need it most.
At Roche, we believe meaningful progress is driven by strong partnerships and a shared commitment to improving global health.
Our long-term support of the World Federation of Hemophilia WFH Humanitarian Aid Program reflects this commitment, helping expand access to care for people living with inherited bleeding disorders in low- and middle-income countries.
By working together across the healthcare ecosystem, we can help reduce disparities in care, strengthen health systems, and create a future where more people with haemophilia have the opportunity to receive timely, life-changing treatment.
Learn how collaboration continues to shape the future of haemophilia care.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question